We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLAP
126
DELISTED
Terran Orbital Corporation
LLAP
$4.72M 0.06%
3,600,000
-12,700,000
-78% -$12.8M
RMTI icon
127
Rockwell Medical
RMTI
$28.3M
$4.37M 0.06%
262,964
+77,764
+42% +$1.13M
STKH
128
Steakholder Foods
STKH
$1.38M
$4.32M 0.06%
6,162
+6,136
+23,600% +$4.4M
ZURA icon
129
Zura Bio
ZURA
$554M
$4.24M 0.06%
1,648,000
-176,000
-10% -$624K
SDIG
130
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$4.15M 0.06%
1,000,000
HLF icon
131
Herbalife
HLF
$1.24B
$3.82M 0.05%
380,000
AWH
132
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$3.59M 0.05%
+1,157,000
New +$5M
CROX icon
133
Crocs
CROX
$6.47B
$3.23M 0.04%
22,428
-25,777
-53% -$2.94M
EFTR
134
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$3.21M 0.04%
+223,000
New +$2.67M
IOBT
135
DELISTED
IO Biotech
IOBT
$2.98M 0.04%
1,724,000
-200,000
-10% -$347K
RHP icon
136
Ryman Hospitality Properties
RHP
$7.88B
$2.86M 0.04%
24,744
-35,256
-59% -$4.05M
HST icon
137
Host Hotels & Resorts
HST
$16.1B
$2.55M 0.03%
+123,326
New +$2.48M
CMRX
138
DELISTED
Chimerix, Inc.
CMRX
$2.4M 0.03%
2,264,000
-334,000
-13% -$348K
KYNB
139
CALL
Kyntra Bio
KYNB
$28.2M
$2.35M 0.03%
+40,000
New +$1.72M
WSM icon
140
Williams-Sonoma
WSM
$29.2B
$2.17M 0.03%
13,644
+2,014
+17% +$234K
RH icon
141
RH
RH
$3.64B
$2.14M 0.03%
6,135
+3,471
+130% +$946K
SLGL icon
142
Sol-Gel Technologies
SLGL
$290M
$2.04M 0.03%
207,800
-5,700
-3% -$65.2K
ALRM icon
143
Alarm.com
ALRM
$2.79B
$1.99M 0.03%
27,474
+22,123
+413% +$1.5M
BODI icon
144
The Beachbody Company
BODI
$75.7M
$1.94M 0.03%
202,000
-123,179
-38% -$1.17M
VTGN icon
145
VistaGen Therapeutics
VTGN
$13.2M
$1.92M 0.03%
364,000
-114,000
-24% -$548K
AXDX
146
DELISTED
Accelerate Diagnostics
AXDX
$1.83M 0.02%
+1,846,000
New +$2.92M
LYV icon
147
Live Nation Entertainment
LYV
$42.6B
$1.76M 0.02%
16,607
-71,833
-81% -$6.79M
VIP
148
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$37.5M
$1.58M 0.02%
+450,300
New +$1.85M
MLCO icon
149
Melco Resorts & Entertainment
MLCO
$2.12B
$1.44M 0.02%
+200,000
New +$1.61M
LW icon
150
Lamb Weston
LW
$7.12B
$1.43M 0.02%
+13,407
New +$1.4M

Similar funds

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.